These data indicated a normal intrinsic potential of aromatase activity in ovaries from PCOS patients stimulated with gonadotropins and suggested that PCOS do not develop from inherent ovarian aromatase deficiency. This evidence concerns the gene CYP19A1 and hyperinsulinemic hypoglycemia, familial, 4.